BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 31054892)

  • 21. Loss of
    Chitguppi C; Rabinowitz MR; Johnson J; Bar-Ad V; Fastenberg JH; Molligan J; Berman E; Nyquist GG; Rosen MR; Evans JE; Mardekian SK
    J Neurol Surg B Skull Base; 2020 Dec; 81(6):610-619. PubMed ID: 33381364
    [No Abstract]   [Full Text] [Related]  

  • 22. Oral involvement of sinonasal undifferentiated carcinoma: A case report and immunohistochemical study of a challenging case.
    Gonçalves JM; Scarini JF; Gondak R; Altemani A; Mariano FV
    Oral Oncol; 2022 Mar; 126():105779. PubMed ID: 35183913
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cytopathologic characteristics of SMARCB1 (INI-1) deficient sinonasal carcinoma: A potential diagnostic pitfall.
    Allison DB; Bishop JA; Ali SZ
    Diagn Cytopathol; 2016 Aug; 44(8):700-3. PubMed ID: 27177850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical Implication of Diagnostic and Histopathologic Discrepancies in Sinonasal Malignancies.
    Choi KY; Amit M; Tam S; Bell D; Phan J; Garden AS; Williams MD; Ferrarotto R; El-Naggar AK; Raza SM; DeMonte F; Kupferman ME; Hanna EY; Su SY
    Laryngoscope; 2021 May; 131(5):E1468-E1475. PubMed ID: 32946597
    [TBL] [Abstract][Full Text] [Related]  

  • 25. INI-1 (SMARCB1)-Deficient Undifferentiated Sinonasal Carcinoma: Novel Paradigm of Molecular Testing in the Diagnosis and Management of Sinonasal Malignancies.
    Shaverdashvili K; Azimi-Nekoo E; Cohen P; Akbar N; Ow TJ; Halmos B; Castellucci E
    Oncologist; 2020 Sep; 25(9):738-744. PubMed ID: 32337786
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Sinonasal malignancies with neuroendocrine differentiation: case series and review of literature.
    Menon S; Pai P; Sengar M; Aggarwal JP; Kane SV
    Indian J Pathol Microbiol; 2010; 53(1):28-34. PubMed ID: 20090218
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Sinonasal undifferentiated carcinoma. A rare and aggressive neoplasm of the nasal cavity and paranasal sinuses].
    Reichel O; Ihrler S; Born F; Andratschke M; Rasp G; Hagedorn H
    HNO; 2006 May; 54(5):394-6, 398-9. PubMed ID: 16034634
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metastatic SMARCB1 (INI-1)-Deficient Sinonasal Carcinoma Diagnosed by Endobronchial Ultrasound-Guided Fine-Needle Aspiration (EBUS-FNA): A Potential Diagnostic Pitfall and Review of the Literature.
    McHugh KE; Policarpio-Nicolas MLC
    Acta Cytol; 2019; 63(5):431-437. PubMed ID: 31132763
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of a Unique Sinonasal Undifferentiated Carcinoma Subtype in the Era of SARS-CoV-2.
    Douglas JE; Kaufman AC; Rajasekaran K
    ORL J Otorhinolaryngol Relat Spec; 2021; 83(1):47-51. PubMed ID: 33017834
    [TBL] [Abstract][Full Text] [Related]  

  • 30. SMARCB1 (INI-1) - Deficient sinonasal carcinoma: Report of two cases.
    Vasudevan G; Srinivas SP; Nayal B; Jayaprakash P; Ramaswamy B
    Indian J Pathol Microbiol; 2023; 66(2):352-355. PubMed ID: 37077082
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sinonasal Undifferentiated Carcinoma.
    Abdelmeguid AS; Bell D; Hanna EY
    Curr Oncol Rep; 2019 Feb; 21(3):26. PubMed ID: 30806835
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Poorly differentiated sinonasal tract malignancies: A review focusing on recently described entities.
    Agaimy A
    Cesk Patol; 2016; 52(3):146-53. PubMed ID: 27526015
    [TBL] [Abstract][Full Text] [Related]  

  • 33. SMARCB1(INI1)-deficient sinonasal adenocarcinoma: Report of a case previously diagnosed as high-grade non-intestinal-type sinonasal adenocarcinoma.
    Su YJ; Lee YH; Hsieh MS
    Pathol Int; 2022 Jan; 72(1):53-58. PubMed ID: 34597447
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-grade sinonasal carcinomas and surveillance of differential expression in immune related transcriptome.
    Bell D; Bell A; Ferrarotto R; Glisson B; Takahashi Y; Fuller G; Weber R; Hanna E
    Ann Diagn Pathol; 2020 Dec; 49():151622. PubMed ID: 32927372
    [TBL] [Abstract][Full Text] [Related]  

  • 35. SMARCB1 (INI-1)-deficient carcinomas of the sinonasal tract.
    Bishop JA; Antonescu CR; Westra WH
    Am J Surg Pathol; 2014 Sep; 38(9):1282-9. PubMed ID: 25007146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Sinonasal undifferentiated carcinoma with orbital invasion: report of three cases.
    Sharara N; Muller S; Olson J; Grist WJ; Grossniklaus HE
    Ophthalmic Plast Reconstr Surg; 2001 Jul; 17(4):288-92. PubMed ID: 11476180
    [TBL] [Abstract][Full Text] [Related]  

  • 37. SMARCB1/INI1-deficient sinonasal carcinoma shows methylation of RASSF1 gene: A clinicopathological, immunohistochemical and molecular genetic study of a recently described entity.
    Laco J; Chmelařová M; Vošmiková H; Sieglová K; Bubancová I; Dundr P; Němejcová K; Michálek J; Čelakovský P; Mottl R; Sirák I; Vošmik M; Ryška A
    Pathol Res Pract; 2017 Feb; 213(2):133-142. PubMed ID: 28069272
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Newly Described Tumor Entities in Sinonasal Tract Pathology.
    Bishop JA
    Head Neck Pathol; 2016 Mar; 10(1):23-31. PubMed ID: 26830406
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Impact of Clinical Factors and Treatments on SMARCB1 (INI-1)-Deficient Sinonasal Carcinoma.
    Contrera KJ; Shakibai N; Su SY; Gule-Monroe MK; Roberts D; Brahimaj B; Williams MD; Ferrarotto R; Phan J; Gunn B; Raza S; DeMonte F; Hanna EY
    Otolaryngol Head Neck Surg; 2023 Aug; 169(2):435-440. PubMed ID: 36856048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Leptomeningeal carcinomatosis in sinonasal undifferentiated carcinoma.
    Liu SV; Wagle N; Zada G; Sun B; Go J; Rashtian A
    Head Neck; 2013 Nov; 35(11):E343-5. PubMed ID: 23471826
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.